540737 — Shree Ganesh Remedies Balance Sheet
0.000.00%
- IN₹6.37bn
- IN₹6.47bn
- IN₹1.09bn
- 80
- 17
- 17
- 28
Annual balance sheet for Shree Ganesh Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 65.9 | 38.8 | 112 | 205 | 282 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 187 | 274 | 350 | 230 | 242 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 380 | 449 | 643 | 702 | 776 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 203 | 298 | 764 | 971 | 1,033 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 606 | 770 | 1,438 | 1,709 | 1,919 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 102 | 150 | 237 | 187 | 162 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 106 | 154 | 549 | 488 | 468 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 500 | 616 | 889 | 1,221 | 1,452 |
| Total Liabilities & Shareholders' Equity | 606 | 770 | 1,438 | 1,709 | 1,919 |
| Total Common Shares Outstanding |